內分泌學的檢驗的開發平台 - 開發階段,市場區隔,地區,法規途徑,主要企業
市場調查報告書
商品編碼
1366548

內分泌學的檢驗的開發平台 - 開發階段,市場區隔,地區,法規途徑,主要企業

Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

出版日期: | 出版商: GlobalData | 英文 101 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供內分泌學的檢驗的開發中產品調查分析,包含各開發階段的產品的比較分析,及進行中的臨床試驗資料等全面性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 內分泌學的檢驗 - 開發中產品:各開發階段
  • 內分泌學的檢驗 - 開發中產品:各市場區隔
  • 內分泌學的檢驗 - 開發中產品:各地區
  • 內分泌學的檢驗 - 開發中產品:各法規途徑
  • 內分泌學的檢驗 - 開發中產品:估計核准日

第4章 內分泌學的檢驗 - 正在開發的開發中產品:各企業

  • 內分泌學的檢驗企業 - 開發中產品:各開發階段
  • 內分泌學的檢驗 - 開發中產品:各開發階段

第5章 內分泌學的檢驗的企業和產品概要

第6章 內分泌學的檢驗 - 最近的發展

第7章 附錄

簡介目錄
Product Code: GDME1619EPD

Abstract

GlobalData's Medical Devices sector report, "Endocrinology Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Endocrinology Tests are the reagents used for quantification and detection of endocrine hormones secreted in the human body.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Endocrinology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Endocrinology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Endocrinology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Endocrinology Tests Overview

3 Products under Development

  • 3.1 Endocrinology Tests - Pipeline Products by Stage of Development
  • 3.2 Endocrinology Tests - Pipeline Products by Segment
  • 3.3 Endocrinology Tests - Pipeline Products by Territory
  • 3.4 Endocrinology Tests - Pipeline Products by Regulatory Path
  • 3.5 Endocrinology Tests - Pipeline Products by Estimated Approval Date

4 Endocrinology Tests - Pipeline Products under Development by Companies

  • 4.1 Endocrinology Tests Companies - Pipeline Products by Stage of Development
  • 4.2 Endocrinology Tests - Pipeline Products by Stage of Development

5 Endocrinology Tests Companies and Product Overview

6 Endocrinology Tests- Recent Developments

  • 6.1 Aug 31, 2023: Integrated Diagnostics Holdings Announces Half Year Report
  • 6.2 Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
  • 6.3 Jun 07, 2023: Eckert & Ziegler Strahlen Annual General Meeting Approves Dividend of EUR 0.50 per Share
  • 6.4 Jun 01, 2023: Integrated Diagnostics announces Q1 2023 Results
  • 6.5 Apr 06, 2023: Integrated Diagnostics Holdings Announces Final Results
  • 6.6 Apr 06, 2023: Integrated Diagnostics Holdings concludes 2022 reporting solid 18% growth in non-Covid revenues
  • 6.7 Feb 22, 2023: Novo Nordisk Notice for the Annual General Meeting
  • 6.8 Dec 20, 2022: Eckert & Ziegler Announces Changes in the Supervisory Board
  • 6.9 Dec 19, 2022: Eckert & Ziegler Announces Changes in the Management Board
  • 6.10 Nov 17, 2022: Integrated Diagnostics Holdings 3rd Quarter Results
  • 6.11 Oct 31, 2022: IDH and its Jordanian subsidiary, Biolab, to Launch Greenfield Diagnostic Venture in Saudi Arabia in Partnership with Izhoor Medical, a company owned by Fawaz Alhokair
  • 6.12 Oct 05, 2022: DiaSorin Gets $31M BARDA Funding for Point-of-Care Instrument

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer